Comments
Loading...

Entero Therapeutics

ENTONASDAQ
Logotipo presentado por Benzinga Data
$0.489800
-0.05-9.30%
al cierre: -
$0.489300
-0.0005-0.10%
After hour: 5:14 PM EDT
Los beneficios de Q3 2024 se publicaron el mié nov 13th, antes de la apertura del mercado
Journey Therapeutics, Inc announced it will be merged with Entero Therapeutics (ENTO) on Wednesday, November 13, 2024

Últimas noticias sobre Entero Therapeutics (NASDAQ:ENTO) Bolsa

Entero Therapeutics Bolsa (NASDAQ: ENTO)

There are no results